Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 1,534 | 1,874 | 2,220 | 1,389 | 1,303 |
| Gross Profit | 1,534 | 1,874 | 2,220 | 1,389 | 1,303 |
| Operating Expenses | 36,646 | 36,727 | 32,213 | 33,755 | 37,007 |
| Operating Income | -35,112 | -34,853 | -29,993 | -32,366 | -35,704 |
| Other Income | 851 | 2,546 | 395 | 414 | 1,031 |
| Pre-tax Income | -34,261 | -32,307 | -29,598 | -31,952 | -34,673 |
| Net Income Continuous | -34,261 | -32,307 | -29,598 | -31,952 | -34,673 |
| Net Income | $-34,261 | $-32,307 | $-29,598 | $-31,952 | $-34,673 |
| EPS Basic Total Ops | -4.20 | -4.60 | -4.35 | -4.80 | -5.25 |
| EPS Basic Continuous Ops | -4.19 | -4.47 | -4.41 | -4.85 | -5.27 |
| EPS Diluted Total Ops | -4.20 | -4.60 | -4.35 | -4.80 | -5.25 |
| EPS Diluted Continuous Ops | -4.19 | -4.47 | -4.41 | -4.85 | -5.27 |
| EBITDA(a) | $-33,545 | $-33,498 | $-28,883 | $-31,337 | $-34,180 |